235 related articles for article (PubMed ID: 11964297)
1. Cytokine production and cytolytic mechanism of CD4(+) cytotoxic T lymphocytes in ex vivo expanded therapeutic Epstein-Barr virus-specific T-cell cultures.
Sun Q; Burton RL; Lucas KG
Blood; 2002 May; 99(9):3302-9. PubMed ID: 11964297
[TBL] [Abstract][Full Text] [Related]
2. Disparate cytotoxic activity of nickel-specific CD8+ and CD4+ T cell subsets against keratinocytes.
Traidl C; Sebastiani S; Albanesi C; Merk HF; Puddu P; Girolomoni G; Cavani A
J Immunol; 2000 Sep; 165(6):3058-64. PubMed ID: 10975816
[TBL] [Abstract][Full Text] [Related]
3. Cytolytic CD4(+)-T-cell clones reactive to EBNA1 inhibit Epstein-Barr virus-induced B-cell proliferation.
Nikiforow S; Bottomly K; Miller G; Münz C
J Virol; 2003 Nov; 77(22):12088-104. PubMed ID: 14581546
[TBL] [Abstract][Full Text] [Related]
4. Cytolytic mechanisms and T-cell receptor Vbeta usage by ex vivo generated Epstein-Barr virus-specific cytotoxic T lymphocytes.
Vanhoutte VJ; McAulay KA; McCarrell E; Turner M; Crawford DH; Haque T
Immunology; 2009 Aug; 127(4):577-86. PubMed ID: 19604308
[TBL] [Abstract][Full Text] [Related]
5. IL-2 and antigen dose differentially regulate perforin- and FasL-mediated cytolytic activity in antigen specific CD4+ T cells.
Brown DM; Kamperschroer C; Dilzer AM; Roberts DM; Swain SL
Cell Immunol; 2009; 257(1-2):69-79. PubMed ID: 19338979
[TBL] [Abstract][Full Text] [Related]
6. Preferential utilization of the perforin/granzyme pathway for lysis of Epstein-Barr virus-transformed lymphoblastoid cells by virus-specific CD4+ T cells.
Khanolkar A; Yagita H; Cannon MJ
Virology; 2001 Aug; 287(1):79-88. PubMed ID: 11504544
[TBL] [Abstract][Full Text] [Related]
7. Functional CD4(+) and CD8(+) T-cell responses induced by autologous mitomycin C treated Epstein-Barr virus transformed lymphoblastoid cell lines.
Meij P; Bloemena E; Palmen N; Brink A; Vervoort MB; Meijer CJ; Middeldorp JM
Cell Immunol; 2001 Feb; 208(1):25-33. PubMed ID: 11277616
[TBL] [Abstract][Full Text] [Related]
8. CD4(+) Epstein-Barr virus-specific cytotoxic T-lymphocytes from human umbilical cord blood.
Sun Q; Burton RL; Pollok KE; Emanuel DJ; Lucas KG
Cell Immunol; 1999 Aug; 195(2):81-8. PubMed ID: 10448007
[TBL] [Abstract][Full Text] [Related]
9. Granule exocytosis, and not the fas/fas ligand system, is the main pathway of cytotoxicity mediated by alloantigen-specific CD4(+) as well as CD8(+) cytotoxic T lymphocytes in humans.
Yasukawa M; Ohminami H; Arai J; Kasahara Y; Ishida Y; Fujita S
Blood; 2000 Apr; 95(7):2352-5. PubMed ID: 10733506
[TBL] [Abstract][Full Text] [Related]
10. CD4(+)CD8(dim) T lymphocytes exhibit enhanced cytokine expression, proliferation and cytotoxic activity in response to HCMV and HIV-1 antigens.
Suni MA; Ghanekar SA; Houck DW; Maecker HT; Wormsley SB; Picker LJ; Moss RB; Maino VC
Eur J Immunol; 2001 Aug; 31(8):2512-20. PubMed ID: 11500836
[TBL] [Abstract][Full Text] [Related]
11. Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.
Homma S; Komita H; Sagawa Y; Ohno T; Toda G
Immunology; 2005 Aug; 115(4):451-61. PubMed ID: 16011514
[TBL] [Abstract][Full Text] [Related]
12. Absence of Epstein-Barr virus-specific, HLA class II-restricted CD4+ cytotoxic T lymphocytes in infectious mononucleosis.
Enssle KH; Fleischer B
Clin Exp Immunol; 1990 Mar; 79(3):409-15. PubMed ID: 1690617
[TBL] [Abstract][Full Text] [Related]
13. Role of different lymphocyte subsets in human anti-viral T cell cultures.
Gomez A; Bourgault I; Gomard E; Picard F; Levy JP
Cell Immunol; 1989 Feb; 118(2):312-27. PubMed ID: 2562930
[TBL] [Abstract][Full Text] [Related]
14. Quantitation, selection, and functional characterization of Epstein-Barr virus-specific and alloreactive T cells detected by intracellular interferon-gamma production and growth of cytotoxic precursors.
Koehne G; Smith KM; Ferguson TL; Williams RY; Heller G; Pamer EG; Dupont B; O'Reilly RJ
Blood; 2002 Mar; 99(5):1730-40. PubMed ID: 11861290
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus-transformed B-cells as efficient antigen presenting cells to propagate Aspergillus-specific cytotoxic T-lymphocytes.
Ramadan G
Egypt J Immunol; 2008; 15(1):145-57. PubMed ID: 20306679
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous T cell lymphoma reactive CD4+ cytotoxic T lymphocyte clones display a Th1 cytokine profile and use a fas-independent pathway for specific tumor cell lysis.
Echchakir H; Bagot M; Dorothée G; Martinvalet D; Le Gouvello S; Boumsell L; Chouaib S; Bensussan A; Mami-Chouaib F
J Invest Dermatol; 2000 Jul; 115(1):74-80. PubMed ID: 10886511
[TBL] [Abstract][Full Text] [Related]
17. Role of T-bet, the master regulator of Th1 cells, in the cytotoxicity of murine CD4
Eshima K; Misawa K; Ohashi C; Iwabuchi K
Microbiol Immunol; 2018 May; 62(5):348-356. PubMed ID: 29577371
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo generation of effective Epstein-Barr virus (EBV)-specific CD8+ cytotoxic T lymphocytes from the peripheral blood of immunocompetent Epstein Barr virus-seronegative individuals.
Metes D; Storkus W; Zeevi A; Patterson K; Logar A; Rowe D; Nalesnik MA; Fung JJ; Rao AS
Transplantation; 2000 Nov; 70(10):1507-15. PubMed ID: 11118098
[TBL] [Abstract][Full Text] [Related]
19. B lymphoblastoid cell lines as efficient APC to elicit CD8+ T cell responses against a cytomegalovirus antigen.
Sun Q; Burton RL; Dai LJ; Britt WJ; Lucas KG
J Immunol; 2000 Oct; 165(7):4105-11. PubMed ID: 11034422
[TBL] [Abstract][Full Text] [Related]
20. Mature dendritic cells pulsed with freeze-thaw cell lysates define an effective in vitro vaccine designed to elicit EBV-specific CD4(+) and CD8(+) T lymphocyte responses.
Herr W; Ranieri E; Olson W; Zarour H; Gesualdo L; Storkus WJ
Blood; 2000 Sep; 96(5):1857-64. PubMed ID: 10961887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
